Overview

Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia

Status:
Withdrawn
Trial end date:
2018-12-14
Target enrollment:
Participant gender:
Summary
To evaluate the affect Oxtellar XR (Extended Release) has on neurology patients with trigeminal neuralgia (TN), and if it impacts their quality of life.
Phase:
Phase 4
Details
Lead Sponsor:
University of Colorado, Denver
Treatments:
Oxcarbazepine